Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Amortization of Deferred Charges: 2014-2025

Historic Amortization of Deferred Charges for Viridian Therapeutics, Inc.\DE (VRDN) over the last 7 years, with Sep 2025 value amounting to $102,000.

  • Viridian Therapeutics, Inc.\DE's Amortization of Deferred Charges rose 41.67% to $102,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $367,000, marking a year-over-year decrease of 16.78%. This contributed to the annual value of $377,000 for FY2024, which is 18.93% up from last year.
  • Latest data reveals that Viridian Therapeutics, Inc.\DE reported Amortization of Deferred Charges of $102,000 as of Q3 2025, which was down 0.97% from $103,000 recorded in Q2 2025.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Amortization of Deferred Charges peaked at $128,000 during Q4 2022, and registered a low of $49,000 during Q3 2022.
  • For the 3-year period, Viridian Therapeutics, Inc.\DE's Amortization of Deferred Charges averaged around $91,091, with its median value being $102,000 (2025).
  • Within the past 5 years, the most significant YoY rise in Viridian Therapeutics, Inc.\DE's Amortization of Deferred Charges was 132.08% (2024), while the steepest drop was 52.03% (2024).
  • Viridian Therapeutics, Inc.\DE's Amortization of Deferred Charges (Quarterly) stood at $87,000 in 2021, then spiked by 47.13% to $128,000 in 2022, then fell by 3.91% to $123,000 in 2023, then slumped by 52.03% to $59,000 in 2024, then skyrocketed by 41.67% to $102,000 in 2025.
  • Its Amortization of Deferred Charges was $102,000 in Q3 2025, compared to $103,000 in Q2 2025 and $103,000 in Q1 2025.